Dr. Erhan Aptullahoglu obtained an MSc in Genetics at İstanbul University in Türkiye followed by undertaking a PhD in the Translational Oncology Research Group at Newcastle University, UK. His PhD study mainly focused on targeting the p53 signaling pathway both in vitro and ex vivo using small-molecule inhibitors as emerging cancer therapeutics. He moved to Bilecik Şeyh Edebali University in 2020 and was promoted to assistant professor in 2023. His research topics mainly include cancer research, targeted therapies, p53 signaling, drug resistance, and small-molecule inhibitors of cancer.
Bilecik University
Bilecik, Turkey (Türkiye)
Faculty of Science